FDA 503B outsourcing facilities in Arkansas
Arkansas has 3 FDA-registered 503B outsourcing facilities in the PeptideGrids directory, 3 with FDA drug recalls on record, the earliest registered in 2013. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| SCA Pharmaceuticals | Little Rock | 2013 | 166 |
| OurPharma LLC | Fayetteville | 2019 | 3 |
| Turbare Manufacturing | Conway | 2023 | 1 |
503B compounding in Arkansas
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Arkansas must hold the appropriate state pharmacy license. Verify any facility's current license with the Arkansas State Board of Pharmacy.
Peptides and GLP-1s compounded in Arkansas
Facilities in Arkansas report compounding Semaglutide, Oxytocin to the FDA. PeptideGrids grades the clinical evidence for each. Browse the full GLP-1 and therapeutic peptide databases.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Arkansas?
3 FDA-registered 503B outsourcing facilities are listed in Arkansas on PeptideGrids, the earliest registered in 2013.
Which Arkansas 503B facilities have FDA recalls on record?
3 of the 3 Arkansas facilities have FDA drug recalls on record; the table above shows the count per facility.
How do I verify a pharmacy license in Arkansas?
Use the Arkansas State Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.